Edesa Biotech, Inc. (NASDAQ:EDSA)

About the company

Edesa Biotech, Inc. is a biopharmaceutical company. It focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company product candidate, EB01, is a sPLA2 inhibitor for the topical treatment of chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients. Edesa Biotech was founded in 2007 and is headquartered in Markham, Canada.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

10

$0.00M

Total Revenue

10

Employees

$44.01M

Market Capitalization

-0.46

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 381445.74 82729.00 6.13 22.23 20.75
Merck & Co., Inc. MRK 199942.72 48081.00 7.51 19.73 21.10
Pfizer Inc. PFE 188747.85 50660.00 2.86 11.95 31.17
Eli Lilly & Co. LLY 155261.34 23087.00 52.69 27.37 23.97
AbbVie, Inc. ABBV 145342.96 34057.00 -23.26 17.33 24.65
Bristol Myers Squibb Co. BMY 111198.52 31006.00 2.70 94.54 3.08
Repligen Corp. RGEN 6389.28 286.00 6.13 278.40 8.11
Reata Pharmaceuticals, Inc. RETA 4839.72 20.00 22.93 -15.57 -150.30
Nektar Therapeutics NKTR 4363.04 137.00 3.41 -9.50 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3946.28 1.00 36.49 -6.04 None
Allakos, Inc. ALLK 3152.76 None 6.84 -33.71 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2448.18 891.00 1.74 -8.37 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.72 None 6.80 -18.91 None
IGM Biosciences, Inc. IGMS 2221.15 None 9.79 -40.94 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Apellis Pharmaceuticals, Inc. APLS 2094.84 None 9.25 -5.02 None
Springworks Therapeutics, Inc. SWTX 1695.06 None 5.51 -27.19 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1578.64 30.00 5.62 -22.46 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1495.17 None 9.16 -16.23 None
Tricida, Inc. TCDA 1300.46 None 6.69 -6.16 None
Akcea Therapeutics, Inc. AKCA 1289.13 341.00 2.65 -45.83 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1267.20 None 6.56 -10.47 None
Akero Therapeutics, Inc. AKRO 1135.64 None 9.48 -22.38 None
Odonate Therapeutics, Inc. ODT 1127.52 None 9.24 -10.02 None
Arcutis Biotherapeutics, Inc. ARQT 1074.85 None 4.58 -17.19 None
Phibro Animal Health Corp. PAHC 1060.26 818.00 5.35 28.73 4.49
Athenex, Inc. ATNX 1014.78 123.00 6.22 -9.43 -87.86
Constellation Pharmaceuticals, Inc. CNST 983.36 None 4.63 -10.60 None
G1 Therapeutics, Inc. GTHX 811.30 1.00 3.51 -6.19 None
Gossamer Bio, Inc. GOSS 809.47 None 3.28 -4.07 None
Phathom Pharmaceuticals, Inc. PHAT 750.75 None 4.17 -2.76 None
Quanterix Corp. QTRX 742.50 60.00 6.55 -16.98 -71.52
Krystal Biotech, Inc. KRYS 721.31 None 4.21 -34.78 None
Oric Pharmaceuticals, Inc. ORIC 687.96 None -7.47 -22.75 None
Applied Therapeutics, Inc. APLT 686.84 14.00 4.43 -13.94 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Aprea Therapeutics, Inc. APRE 647.22 None 5.73 -19.14 None
Arcturus Therapeutics Holdings, Inc. ARCT 632.06 19.00 58.58 -22.72 -151.34
Amneal Pharmaceuticals, Inc. AMRX 617.87 1679.00 4.25 -2.84 -11.85
Keros Therapeutics, Inc. KROS 601.74 8.00 -27.18 -28.33 -285.35
Oyster Point Pharma, Inc. OYST 548.10 None 5.51 -9.53 None
Mirum Pharmaceuticals, Inc. MIRM 491.75 None 3.20 -7.26 None
SIGA Technologies, Inc. SIGA 467.40 19.00 5.23 -23.75 -94.00
Biospecifics Technologies Corp. BSTC 462.28 40.00 3.75 19.77 61.80
89bio, Inc. ETNB 457.80 None 5.65 -7.09 None
Fulcrum Therapeutics, Inc. FULC 444.13 1.00 7.48 -6.44 None
Satsuma Pharmaceuticals, Inc. STSA 441.32 None 4.34 -12.13 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
DURECT Corp. DRRX 395.25 28.00 30.36 -16.35 -82.94
Kala Pharmaceuticals, Inc. KALA 383.04 6.00 4.19 -4.17 None
TCR2 Therapeutics, Inc. TCRR 383.04 None 2.62 -38.00 None
Crinetics Pharmaceuticals, Inc. CRNX 382.56 1.00 4.83 -6.56 -447.78
Relmada Therapeutics, Inc. RLMD 380.88 0.00 5.68 -31.82 -877.66
Ocular Therapeutix, Inc. OCUL 357.12 6.00 -43.76 -3.90 None
Ovid Therapeutics, Inc. OVID 344.25 None 8.14 -5.28 None
Osmotica Pharmaceuticals Plc OSMT 343.44 232.00 2.61 -1.25 -115.44
Aeglea Biotherapeutics, Inc. AGLE 303.27 4.00 9.57 -3.78 -523.27
Urovant Sciences Ltd. UROV 285.60 None -5.06 -1.98 None
IDEAYA Biosciences, Inc. IDYA 270.40 None 4.11 -6.20 None
Spero Therapeutics, Inc. SPRO 268.28 12.00 3.53 -3.30 -656.72
HOOKIPA Pharma, Inc. HOOK 267.80 13.00 2.42 -5.92 -333.02
Gritstone Oncology, Inc. GRTS 255.60 4.00 2.29 -2.45 None
AMAG Pharmaceuticals, Inc. AMAG 240.04 321.00 0.92 -0.65 -115.05
Lannett Co., Inc. LCI 234.84 542.00 0.80 -7.72 -5.77
Verrica Pharmaceuticals, Inc. VRCA 219.00 None 4.00 -7.18 None
KalVista Pharmaceuticals, Inc. KALV 211.68 12.00 2.34 -6.53 -263.38
Kaleido Biosciences, Inc. KLDO 207.90 None 7.37 -2.84 None
Sutro Biopharma, Inc. STRO 200.79 41.00 3.81 -3.29 -148.06
Veru, Inc. VERU 200.20 39.00 6.70 -20.53 -25.53
Galera Therapeutics, Inc. GRTX 187.25 None 3.50 -2.85 None
LogicBio Therapeutics, Inc. LOGC 175.03 1.00 5.28 -4.11 None
Protara Therapeutics, Inc. TARA 173.10 None 2.60 -11.23 None
Liquidia Technologies, Inc. LQDA 166.10 8.00 13.02 -3.37 -602.17
Avenue Therapeutics, Inc. ATXI 156.00 532.00 28.68 -10.71 26.69
Cyclerion Therapeutics, Inc. CYCN 153.49 6.00 1.93 -1.48 None
Corvus Pharmaceuticals, Inc. CRVS 147.45 None 2.36 -3.12 None
Lyra Therapeutics, Inc. LYRA 145.68 1.00 -1.24 -8.73 -491.16
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Evelo Biosciences, Inc. EVLO 144.00 None 5.29 -1.64 None
scPharmaceuticals, Inc. SCPH 143.36 119.00 3.66 -4.57 -27.05
PhaseBio Pharmaceuticals, Inc. PHAS 134.85 2.00 2.50 -2.82 None
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 125.60 None 2.93 -2.55 None
Harrow Health, Inc. HROW 122.46 51.00 7.85 -4.96 -47.54
TFF Pharmaceuticals, Inc. TFFP 117.80 None 4.56 -3.04 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
NeuBase Therapeutics, Inc. NBSE 117.04 None 49.18 -2.62 None
Ayala Pharmaceuticals, Inc. AYLA 112.20 3.00 -2.64 -5.44 -679.19
Evolus, Inc. EOLS 100.50 45.00 1.80 -0.99 -217.51
Trevi Therapeutics, Inc. TRVI 98.82 None 2.10 -3.37 None
Eton Pharmaceuticals, Inc. ETON 94.32 1.00 10.27 -4.72 None
Milestone Pharmaceuticals, Inc. MIST 93.86 None 0.93 -1.51 None
EyePoint Pharmaceuticals, Inc. EYPT 78.49 26.00 5.54 -1.60 -196.30
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Clearside Biomedical, Inc. CLSD 72.57 6.00 9.32 -4.12 -293.61
Xeris Pharmaceuticals, Inc. XERS 72.24 4.00 3.58 -0.56 None
Navidea Biopharmaceuticals, Inc. NAVB 68.17 1.00 -50.13 -6.17 -65.13
Baudax Bio, Inc. BXRX 65.70 None -1.79 -0.94 None
BiomX, Inc. PHGE 60.06 None 1.58 -1.40 None
Genprex, Inc. GNPX 59.60 None 5.06 -4.36 None
Assertio Therapeutics, Inc. ASRT 57.60 192.00 1.00 -0.35 -83.99
Aridis Pharmaceuticals, Inc. ARDS 55.44 1.00 -22.81 -1.90 -851.00
Aerpio Pharmaceuticals, Inc. ARPO 54.12 20.00 1.63 -2.87 -51.58
Menlo Therapeutics, Inc. MNLO 48.72 2.00 4.10 -0.52 -483.51
Eyenovia, Inc. EYEN 45.12 None 4.55 -2.20 None
Edesa Biotech, Inc. EDSA 44.01 0.00 6.27 -0.46 -395.23
Annovis Bio, Inc. ANVS 42.49 None 3.89 -33.72 None
Moleculin Biotech, Inc. MBRX 40.48 None 3.52 -4.40 None
Acer Therapeutics, Inc. ACER 36.30 3.00 2.65 -1.39 -274.69
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Citius Pharmaceuticals, Inc. CTXR 34.83 None 2.58 -2.02 None
AgeX Therapeutics, Inc. AGE 33.82 2.00 -44.50 -2.78 -658.11
Oncternal Therapeutics, Inc. ONCT 33.67 3.00 4.32 -1.34 -225.89
Mannatech, Inc. MTEX 33.40 156.00 1.41 7.52 3.45
Allena Pharmaceuticals, Inc. ALNA 33.35 None 4.39 -0.77 None
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Aileron Therapeutics, Inc. ALRN 30.80 None 4.23 -1.16 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Hoth Therapeutics, Inc. HOTH 25.40 None 7.06 -2.82 None
Millendo Therapeutics, Inc. MLND 25.20 0.00 0.59 -0.54 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.77 0.00 0.94 -0.95 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 19.76 1.00 8.67 -1.18 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Adial Pharmaceuticals, Inc. ADIL 15.00 None 3.66 -1.97 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.38 5.00 -3.31 -0.46 -602.34
PDS Biotechnology Corp. PDSB 13.93 None 1.54 -0.55 None
Titan Pharmaceuticals, Inc. TTNP 12.07 4.00 5.03 -0.67 -437.91
Novus Therapeutics, Inc. NVUS 8.01 None 0.69 -0.38 None
Brickell Biotech, Inc. BBI 4.68 5.00 1.53 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Edesa Biotech Receives Regulatory Approval to Initiate COVID-19 Study

24d ago, source: YAHOO!

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs.

Price Over Earnings Overview: Edesa Biotech

25d ago, source: YAHOO!

In the current session, Edesa Biotech Inc. (NASDAQ: EDSA) is trading at $6.29, after a 118.40% increase. Over the past month, the stock increased by 113.95%, and in the past year, by 61.28%.

Stock Alert: Edesa Biotech Shares Surge 160% On Regulatory Approval To Initiate COVID-19 Study

24d ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net (RTTNews) - Shares of Edesa Biotech Inc. (EDSA) are rallying over 160% in pre-market today, after the company announced ...

Stock Alert: Edesa Biotech Skyrockets On Regulatory Approval For COVID-19 Study

24d ago, source: Nasdaq

(RTTNews) - Shares of Edesa Biotech Inc. (EDSA) are surging more than 124 percent or $3.59 in Monday's morning trade at $6.47. The stock has traded in a range of $1.58 to $13.56 in the past 52 weeks.

Edesa Shares Double Upon Gaining Approval to Initiate Phase 2/3 COVID-19 Study

24d ago, source: streetwisereports.com

Clinical-stage biopharmaceutical company Edesa Biotech Inc. (EDSA:NASDAQ), which is focused on developing treatments for inflammatory and immune-related diseases, today announced that "it has received ...

Edesa Skyrockets On Health Canada Approval Of COVID-19 Study

24d ago, source: MSN

Canadian biopharma Edesa Biotech Inc (NASDAQ: EDSA) is seeing its shares surge higher Monday after it announced regulatory approval to begin a late-stage study of its investigational asset for ...

Edesa Biotech Receives Regulatory Approval to Initiate COVID-19 Study

25d ago, source: MarketWatch

June 15, 2020 (ACCESSWIRE via COMTEX) -- TORONTO, ON / ACCESSWIRE / June 15, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has received expedited approval ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.